Carnegie Mellon University

Steve BollingerSteve Bollinger

Adjunct Instructor of Entrepreneurship

Stephen Bollinger brings a very diverse background to the medical device and biologic marketplace. He has held multiple leadership positions from a Founder, CEO, President and Chief Operations Officer of early-stage companies to a broad spectrum of roles. These roles include global operations, marketing, product management and sales. He is an Adjunct Professor at Carnegie Mellon Universities Tepper School of Business. He has a track record of success in developing new companies from start-up, through M&A. Steve has sold his last four (4) companies in succession.

He founded Rinovum Women’s Health in 2010. In 2019, he sold a division of Rinovum named “The Stork® while creating an entirely new entity Ovala, Inc. in 2016 that is currently in the market with Revive® for Light Bladder Leaks. Prior to founding Rinovum Women’s Health in 2010, Bollinger was an active Executive-in-Residence at Pittsburgh Life Sciences Greenhouse where he supported building and investing is early-stage life science companies from 2009 to 2010. Prior to the Pittsburgh Life Sciences Greenhouse, Bollinger was an Executive-in-Residence at Highland Capital Partners where he supported the healthcare segment of the firm in 2009. From 2005 to 2008 he was President and Chief Operations Officer at Pervasis Therapeutics, Inc., which was a privately held biologically active medical device company pioneering regenerative and cell-based therapies with respect to interventional cardiology, interventional radiology and vascular surgery. Pervasis was sold to Shire. From 2000 to 2004, he was a founder and the Chief Operating Officer of Angiolink Corporation, a privately held medical device company. With responsibilities for overall operations, he sold the company to Medtronic Corporation in fall of 2004. From 1997 to 1999 Mr. Bollinger was the Vice President of Research, Development and Operations for Byron Medical and held overall responsibility for corporate operations. He sold the company to Mentor Corporation in 1999. From 1991 to 1997, Mr. Bollinger has held positions at Mentor Corporation, American Hydro-Surgical Instruments, and Deknatel, in a variety of roles ranging from Sales to Product Development and Marketing Management.

Mr. Bollinger served as an artillery officer in the United States Army from 1987 to 1991, and during his service he led and supervised reconnaissance teams into combat during Operation Desert Storm. In 1991, he was awarded the Bronze Star Medal for exceptional meritorious service during combat. During his service, he graduated from the United States Army Airborne and Ranger Schools. Mr. Bollinger currently holds seven medical patents, with multiple pending. He studied at Oklahoma City University for his MBA and is a graduate of the United States Military Academy West Point with a B.S. in mechanical engineering.